What drives KALA BIO KALA profit more than anything else Q4 2025 Profit Exceeds Views KALV KalVista Pharmaceuticals posts 291 Q4 2025 EPS surprise shares dip marginally in daily trading OACCU Oaktree outlines targeted life sciences acquisition priorities in its latest quarterly earnings update LANV Lanvin management details global luxury segment expansion plans to fuel future revenue growth Eisen Secures 185 Million to Aid Americans in Recovering Forgotten Funds Before State Escheatment UNF Survey Signals Expansion for First Coast Manufacturing Sector in April Onfolio Holdings ONFO Surges 291 Nearing 111 Resistance 20260514